Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Quest Diagnostics (DGX) PT Raised to $115 at Deutsche Bank
April 21, 2017 8:26 AM EDTDeutsche Bank raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $108.00) while maintaining a Buy rating.
... MoreQuest Diagnostics (DGX) PT Raised to $104.50 at Evercore ISI
April 20, 2017 1:03 PM EDTEvercore ISI raised its price target on Quest Diagnostics (NYSE: DGX) to $104.50 (from $102.00) while maintaining an In Line rating.
Analyst Ross Muken said DGX has become one of the most consistent companies in healthcare. That said, valuation keeps them on the... More
Quest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook
April 20, 2017 6:47 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.33, $0.15 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.87 billion.
"We delivered strong growth across the board in the first quarter with gains in revenues,... More
